| Financial Year |
March 31 2023 |
| Monetary Funds |
6,204,294,194.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,349,440.00 |
| Accounts Receivable |
159,590,026.25 |
| Advances to Suppliers |
652,055,371.55 |
| Other Receivables |
2,586,406,192.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
23,172,178,472.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,536,332,060.00 |
| Total Current Assets |
34,358,871,766.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,388,591.25 |
| Long-term Equity Investment |
463,240,332.47 |
| Investment Properties |
885,654,295.52 |
| Fixed Assetes |
133,061,365.12 |
| Under-construction Projects |
5,444,848.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,335,600.20 |
| R&D expenses |
-- |
| Goodwill |
132,841.35 |
| Long-Term Deferred and Prepaid Expenses |
9,605,138.92 |
| Deferred Income Tax Assets |
70,250,303.05 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,591,113,316.36 |
| Total Assets |
35,949,985,082.98 |
| Short-Term Loans |
581,003,749.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
935,405,805.58 |
| Accounts Received In Advance |
19,285,833.91 |
| Employee Compensation Payable |
22,199,434.93 |
| Taxes Payable |
691,022,639.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,765,800,112.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,400,442,616.37 |
| Other Current Liabilities |
1,008,115,424.90 |
| Sub-Total of Current Liabilities |
17,939,215,317.46 |
| Long-term Loans |
7,642,636,081.20 |
| Bonds Payable |
843,108,045.32 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
717,455.24 |
| Deferred Income Tax Liabilities |
2,144,232.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,519,495,937.84 |
| Total Liabilities |
26,458,711,255.30 |
| Paid-In Capital(Or Share Stock) |
803,291,894.00 |
| Capital Surplus |
1,792,491,531.00 |
| Surplus Reserve |
534,111,179.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,312,989,426.42 |
| Minority Stockholder's Interest |
3,048,389,796.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,442,884,030.97 |
| Owner's Equity（Stockholder's Equity） |
9,491,273,827.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,949,985,082.98 |
